About us
Board of directors

Lone Carlbom
Your Content Goes Here
Your Content Goes Here
Recognized leader with more than 25 years from Life Science and Biotech industry. Experience covering business development, product management, change management and personal & organizational development in both local and global organizations. Strong passion for delivering solutions that meets both our customers and Bio-Works needs to create the best possible business value.
Shares: 434.941
Options: 10.000
Arne Hauge
Your Content Goes Here
Your Content Goes Here
Experienced Chief Financial Officer who started two “start-ups”, between 2003 and 2008: Halebop in Sweden and Yoigo in Spain. Almost two decades at Telia Company in various roles and areas such as Investment Manager, CFO, COO, CCO, Strategy & Business Development, Change Management & M&A. Previous to Telia, Arne worked at AGA AB, including two years working in Caracas, Venezuela.
Options: 22.500

Roberto Gatti
Your Content Goes Here
Your Content Goes Here
After his Ph.D. in organic chemistry, he has gained 30 years of experience across the life science, pharma, chemical, biotech, and the food sector.
Throughout his career, he has been involved in a wide range of areas including R&D, scale-up, project management, production engineering, contract manufacturing (CMO), technology transfer (TT), production support, marketing and customer relations, education, quality control, and quality assurance.
His expertise spans both local and global leadership roles, and he brings many years of experience as a line manager. He is driven by a passion for delivering solutions that meet customer needs to generate optimal business value while maintaining the right standards of quality.

Maria Åberg
Your Content Goes Here
Your Content Goes Here
Experienced Manufacturing Manager with a demonstrated history of working in the health care industry. Strong operations professional skilled in Biotechnology, Design Control, Validation, GMP, and Lean Manufacturing.
Shares: 5000
Options: 15.000
Marc Iversen
Your Content Goes Here
Your Content Goes Here

Elisa-Charlott-Schöneweiss
Your Content Goes Here
Your Content Goes Here

Casper Paludan
Your Content Goes Here
Your Content Goes Here
Dave Lescinski
Your Content Goes Here
Your Content Goes Here
Daniel Herneson
Your Content Goes Here
Your Content Goes Here
Gabriel Halat
Your Content Goes Here
Your Content Goes Here

Mikael Andersson Schönn
Your Content Goes Here
Your Content Goes Here

Anna Wehlin
Your Content Goes Here
Your Content Goes Here
Martin Enmark
Your Content Goes Here
Your Content Goes Here

Peter Ehrenheim
Your Content Goes Here
Your Content Goes Here
Peter has an operative background from Pharmacia Biotech, Amersham and GE Healthcare. He was general manager for Separations Division 1999-2006, and from 2006-2011, general manager for GE’s Life Sciences business which was acquired by Danaher in 2020. From 2011, he has worked as an entrepreneur with different companies and board roles. He is presently chairman in Färjsundet Industri AB and Sophion A/S, and a board member at Grönsöö Säteri AB.
Independence: Independent in relation to the company and the company management, independent in relation to major shareholders.
Shares: 782.031 privately held; and 3.070.938 via Färjsundet AB

Peter Nählstedt
Your Content Goes Here
Your Content Goes Here
Peter Nählstedt has more than 20 years of operational experience from leading positions in life science and industry. His experience includes CEO of Probi AB (publ), Director Europe Trelleborg Marine Systems and General Manager North America BioProcess at GE Healthcare. He has also worked as consultant and advisor and held roles in marketing, sales and strategy at Sigma-Aldrich and GE Healthcare. Today he works as CEO of SenzaGen AB (publ) and is chairman of the board at Supersynbiotics AB and holds board positions at Bio-Works and Optiome AB.
Independence: Independent in relation to the company and the company management, independent in relation to major shareholders.
Shares: 165.000

Jonas Ahlén
Your Content Goes Here
Your Content Goes Here
Jonas Ahlén has over twenty years of experience in international financial markets. He has served as an advisor to investment funds and as a board member of healthcare and technology businesses in Europe and the UK. He is the CEO and board member of AB Bonit Invest, a family-owned investment company with a strong focus on healthcare investments. He has a background in institutional asset management, most recently as CEO of Storebrand Asset Management in Sweden. He started his career in investment banking, including with JP Morgan in London. He is the owner and founder of Ahlen Enterprises AB.
Independence: Independent in relation to the company and the company management, independent in relation to major shareholders.
Shares: 518.096 privately held; and 3.490.005 via. AB Bonit Invest

Thomas Gür
Your Content Goes Here
Your Content Goes Here
Thomas Gür has more than 40 years of experience in the areas of communication, investor relations, media handling, and public relations. He has served as an advisor on international affairs and as a board member of both listed and unlisted companies. He is the Chairman of the Board of Tellusgruppen AB, owner and founder of Ölander & Gür AB, and Klasse AB. He served as the external CEO of Accelerator Nordic AB from 2013 to 2014. He has also had assignments as a political commentator on the editorial pages for SvD, Göteborgs Posten, Finanstidningen, and ÖstgötaCorren. He has served as a former UN officer and press secretary for the Supreme Commander of the Swedish Defence Forces and of the Ministry of Trade and Commerce.
Independence: Independent in relation to the company and the company management, independent in relation to major shareholders.
Shares: 366.000 via Ölander & Gür AB
| Name | Title | Shares | Options or warrants |
|---|---|---|---|
| Peter Ehrenheim | Chairman of the Board | 782.031 privately held; and 3.070.938 via Färjsundet AB | |
| Peter Nählstedt | Board director | 165.000 | |
| Jonas Ahlén | Board director | 518.096 privately held; and 3.490.005 via. AB Bonit Invest | |
| Thomas Gür | Board director | 366.000 via Ölander & Gür AB |
Shareholding information last updated 2026-01-20
